Bioinformatics Inventions: Patenting challenges at the interface of computer and life sciences

Frances Salisbury

Frances Salisbury
27 Feb 2019

We are entering an age of precision medicine, with patients receiving tailored treatments, selected and sometimes even specifically designed for their.

How to patent AI technology at the EPO

Emma Graham

Emma Graham
26 Feb 2019

Once only a figment of the imagination in literature such as Mark Shelley’s Frankenstein, artificial intelligence, commonly known as AI, is now realised.

Self-driving vehicles: what do consumers think (and want)?

Christoph Moeller

Christoph Moeller
25 Feb 2019

As a survey of 25,000 consumers in 20 countries, and a study that has been conducted annually over the past ten years, the Deloitte Global Automotive.

Is your interest legitimate? New referral to the EBOA on double patenting

Simon Kiddle

Simon Kiddle
22 Feb 2019

EPO Board of Appeal 3.3.01 is referring a number of questions regarding double patenting to the Enlarged Board of Appeal.  The answers may force.

Building an IP portfolio: Nine tips for success

Matthew Smith

Matthew Smith
15 Feb 2019

Companies need to think carefully about how they protect, manage and leverage the various intellectual property (IP) assets across their business..

Plant related inventions: clarity at last?

Andrew Tindall

Andrew Tindall
06 Feb 2019

As we reported previously, EPO Technical Board of Appeal 3304 recently ruled that a controversial prohibition at the EPO against the grant of patents for.

Fighting cancer with CAR-T therapies

Frances Salisbury

Frances Salisbury
04 Feb 2019

In September 2018, NHS England entered into an agreement with Novartis to offer its CAR-T therapy, Kymriah, to children with advanced leukaemia. This was.

Commercialising genomic research in the US: tips for obtaining patent protection

Emily Hayes

Emily Hayes
30 Jan 2019

The field of genomics has seen incredible advances over the past few decades. Technological developments coupled with decreasing costs have fuelled this .

China - a key player in the global precision medicine race

Frances Salisbury

Frances Salisbury
30 Jan 2019

With a growing economy, and a large, ageing population, China is attracting attention from global pharmaceutical and biotechnology companies. China’s home.

Autonomous driving: the IP twists and turns

Christoph Moeller

Christoph Moeller
28 Jan 2019

Autonomous driving (AD) is on everyone’s lips when it comes to the next big thing in the automotive industry, especially as it is nowadays regularly.

Autonomous vehicles - the race to innovate

Christoph Moeller

Christoph Moeller
22 Jan 2019

The future of the automotive sector will be fundamentally different from its past. Electric vehicles (EVs) are disrupting the rule of the internal.

Brexit: draft withdrawal agreement rejected

Robert Watson

Robert Watson
16 Jan 2019

Despite the continued uncertainty caused by the rejection of the draft withdrawal agreement by the UK Parliament on the evening of 15 January 2019,.

Blockchain: the next patent boom

Graeme Moore

Graeme Moore
13 Dec 2018

Emma Graham and Graeme Moore recently attended the EPO’s “Patenting Blockchain” conference in The Hague – purportedly the world’s first conference of.

Precision medicine: ethics, regulation and patent law

Frances Salisbury

Frances Salisbury
13 Dec 2018

New genomic and proteomic analysis technologies allow for diagnosis and prognosis of patients with greater accuracy than ever before. Indeed, due to the.

Future mobility: the new direction of transport

Christoph Moeller

Christoph Moeller
11 Dec 2018

Massive social, economic and technology trends are converging to change mobility - how we move things from point A to point B, be they people, goods or.

Plant related inventions: the saga continues

Frances Salisbury

Frances Salisbury
10 Dec 2018

We may be approaching the end of the year, but the saga of patents for plant related inventions at the EPO continues to develop.  The Administrative.

Patent protection: five tips for biotech start-ups

Adam Gregory

Adam Gregory
10 Dec 2018

Early-stage biotech companies are often founded based on the exciting results of pre-clinical research relating to a new product or treatment. However,.

Clovis Oncology success in European Opposition Proceedings related to Rubraca®

Richard Clegg

Richard Clegg
10 Dec 2018

Clovis Oncology has announced that the European Patent Office (EPO) last week upheld claims of European Patent 2534153 in amended form covering certain.

The importance of Innovation Hubs in the UK's North West Region

Anna Mudge

Anna Mudge
02 Dec 2018

Life science ‘start-ups’, ‘spin-outs’ and SMEs are some of the most innovative businesses and are often based upon truly great technology and ideas..

Brexit: what does the draft withdrawal agreement mean for IP?

Robert Watson

Robert Watson
15 Nov 2018

A further step towards a withdrawal agreement between the UK and EU27 occurred on 14 November 2018 with the publication of the fully negotiated version of.